Structural diversity of biologically interesting datasets: A scaffold analysis approach

Journal of Cheminformatics

Volumn 3, Issue 8, 2011, Pages

  Khanna, Varun ^a   Ranganathan, Shoba ^a,b  

^a MACQUARIE UNIVERSITY   (Australia)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84862674930     PISSN: None     EISSN: 17582946     Source Type: Journal    
DOI: 10.1186/1758-2946-3-30     Document Type: Article

References (39)

1. Patterson DE, Cramer RD, Ferguson AM, Clark RD, Weinberger LE: Neighborhood behavior: a useful concept for validation of "molecular diversity" descriptors. J Med Chem 1996, 39(16):3049-3059. (Pubitemid 26260310)
2. Dobson CM: Chemical space and biology. Nature 2004, 432(7019):824-828. (Pubitemid 40037137)
3. Wang Y, Xiao J, Suzek TO, Zhang J, Wang J, Bryant SH: PubChem: a public information system for analyzing bioactivities of small molecules. Nucleic Acids Res 2009, 37 Web Server: W623-633.
4. Lipinski CA, Lombardo F, Dominy BW, Feeney PJ: Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev 2001, 46(1-3):3-26. (Pubitemid 33653411)
5. Bemis GW, Murcko MA: The properties of known drugs. 1. Molecular frameworks. J Med Chem 1996, 39(15):2887-2893. (Pubitemid 26251026)
6. Dobson PD, Patel Y, Kell DB: 'Metabolite-likeness' as a criterion in the design and selection of pharmaceutical drug libraries. Drug Discov Today 2009, 14(1-2):31-40.
7. Grabowski K, Schneider G: Properties and Architecture of Drugs and Natural Products Revisited. Curr Chem Biol 2007, 1:115-127.
8. Siegel MG, Vieth M: Drugs in other drugs: a new look at drugs as fragments. Drug Discov Today 2007, 12(1-2):71-79. (Pubitemid 46014488)
9. Medina-Franco JL, Martinez-Mayorgaa K, Bender A, Sciorc T: Scaffold Diversity Analysis of Compound Data Sets Using an Entropy-Based Measure. QSAR Comb Sci 2009, 28(11-12):1551-1560.
10. Singh N, Guha R, Giulianotti MA, Pinilla C, Houghten RA, Medina-Franco JL: Chemoinformatic analysis of combinatorial libraries, drugs, natural products, and molecular libraries small molecule repository. J Chem Inf Model 2009, 49(4):1010-1024.
11. Hert J, Irwin JJ, Laggner C, Keiser MJ, Shoichet BK: Quantifying biogenic bias in screening libraries. Nat Chem Biol 2009, 5(7):479-483.
12. Khanna V, Ranganathan S: Physicochemical property space distribution among human metabolites, drugs and toxins. BMC Bioinformatics 2009, 10(Suppl 15):S10.
13. Schneider P, Schneider G: Collection of Bioactive Reference Compounds for Focused Library Design. QSAR & Combinatorial Science 2003, 22(7):713-718. (Pubitemid 37391067)
14. Rogers D, Hahn M: Extended-connectivity fingerprints. J Chem Inf Model 2010, 50(5):742-754.
15. Wang Y, Bajorath J: Development of a compound class-directed similarity coefficient that accounts for molecular complexity effects in fingerprint searching. J Chem Inf Model 2009, 49(6):1369-1376.
16. Schuster D, Laggner C, Langer T: Why drugs fail-a study on side effects in new chemical entities. Curr Pharm Des 2005, 11(27):3545-3559. (Pubitemid 41300759)
17. Gut J, Bagatto D: Theragenomic knowledge management for individualised safety of drugs, chemicals, pollutants and dietary ingredients. Expert Opin Drug Metab Toxicol 2005, 1(3):537-554.
18. Ganesan A: The impact of natural products upon modern drug discovery. Curr Opin Chem Biol 2008, 12(3):306-317.
19. Oprea TI, Davis AM, Teague SJ, Leeson PD: Is there a difference between leads and drugs? A historical perspective. J Chem Inf Comput Sci 2001, 41(5):1308-1315.
20. Wetzel S, Klein K, Renner S, Rauh D, Oprea TI, Mutzel P, Waldmann H: Interactive exploration of chemical space with Scaffold Hunter. Nat Chem Biol 2009, 5(8):581-583.
21. Krueger BA, Dietrich A, Baringhaus KH, Schneider G: Scaffold-hopping potential of fragment-based de novo design: the chances and limits of variation. Comb Chem High Throughput Screen 2009, 12(4):383-396.
22. Wishart DS, Knox C, Guo AC, Cheng D, Shrivastava S, Tzur D, Gautam B, Hassanali M: DrugBank: a knowledgebase for drugs, drug actions and drug targets. Nucleic Acids Res 2008, 36 Database: D901-906. (Pubitemid 351149842)
23. Kanehisa M, Araki M, Goto S, Hattori M, Hirakawa M, Itoh M, Katayama T, Kawashima S, Okuda S, Tokimatsu T, et al: KEGG for linking genomes to life and the environment. Nucleic Acids Res 2008, 36 Database: D480-484. (Pubitemid 351149770)
24. Wishart DS, Knox C, Guo AC, Eisner R, Young N, Gautam B, Hau DD, Psychogios N, Dong E, Bouatra S, et al: HMDB: a knowledgebase for the human metabolome. Nucleic Acids Res 2009, 37 Database: D603-610.
25. Romero P, Wagg J, Green ML, Kaiser D, Krummenacker M, Karp PD: Computational prediction of human metabolic pathways from the complete human genome. Genome Biol 2005, 6(1):R2.
26. Schellenberger J, Park JO, Conrad TM, Palsson BO: BiGG: a Biochemical Genetic and Genomic knowledgebase of large scale metabolic reconstructions. BMC Bioinformatics 2010, 11:213.
27. Richard AM, Williams CR: Distributed structure-searchable toxicity (DSSTox) public database network: a proposal. Mutat Res 2002, 499(1):27-52. (Pubitemid 34137072)
28. Contrera JF, Jacobs AC, DeGeorge JJ: Carcinogenicity testing and the evaluation of regulatory requirements for pharmaceuticals. Regul Toxicol Pharmacol 1997, 25(2):130-145 (Pubitemid 27220196)
29. International Toxicity Estimate for Risk database (TERA). [http://www.tera org/iter]
30. Wullenweber A, Kroner O, Kohrman M, Maier A, Dourson M, Rak A, Wexler P, Tomljanovic C: Resources for global risk assessment: the International Toxicity Estimates for Risk (ITER) and Risk Information Exchange (RiskIE) databases. Toxicol Appl Pharmacol 2008, 233 (1) 45-53
31. Schmidt U, Struck S, Gruening B, Hossbach J, Jaeger IS, Parol R, Lindequist U, Teuscher E, Preissner R: SuperToxic: a comprehensive database of toxic compounds. Nucleic Acids Res 2009, 37 Database: D295-299.
32. Irwin JJ, Shoichet BK: ZINC-a free database of commercially available compounds for virtual screening. J Chem Inf Model 2005, 45(1):177-182 (Pubitemid 40736970)
33. BioNET. [http://www.keyorganics.co.uk/Downloads]
34. Maybridge. [http://www.maybridge.com/default.aspx]
35. National Cancer Institute (NCI). [http://cactus.nci.nih.gov/download/nci/ ]
36. Overington J: ChEMBL. An interview with John Overington, team leader, chemogenomics at the European Bioinformatics Institute Outstation of the European Molecular Biology Laboratory (EMBL-EBI). Interview by Wendy A. Warr. J Comput Aided Mol Des 2009, 23(4):195-198.
37. SciTegic Pipeline Pilot. [http://accelrys.com/products/scitegic/]
38. Ghose AK, Crippen GM: Atomic physicochemical parameters for three-dimensional-structure-directed quantitative structure-activity relationships. 2. Modeling dispersive and hydrophobic interactions. J Chem Inf Comput Sci 1987, 27(1):21-35
39. Milne GW, Nicklaus MC, Driscoll JS, Wang S, Zaharevitz D: National Cancer Institute Drug Information System 3D database. J Chem Inf Comput Sci 1994, 34(5):1219-1224.